Oncogenic Osteomalacia

Also known as: Tumor Induced Oncogenic Osteomalacia / Tumor-Induced Osteomalacia / Tumor-induced Osteomalacia (TIO) / Tumor Induced Osteomalacia (TIO) / Osteomalacia due to neoplastic disease (disorder) / Hypophosphataemic osteomalacia / Hypophosphatemic osteomalacia

DrugDrug NameDrug Description
DB14012BurosumabA fibroblast growth factor 23 blocking antibody used to treat X-linked hypophosphatemia.
DrugDrug NameTargetType
DB14012BurosumabFibroblast growth factor 23target
DrugDrug NamePhaseStatusCount
DB13925Dotatate gallium Ga-680Unknown Status1
DB13925Dotatate gallium Ga-681Unknown Status1
DB16323Satoreotide tetraxetan1Unknown Status1
DB14012Burosumab2Completed1
DB11886Infigratinib2Terminated1
DB14012Burosumab4Active Not Recruiting1
DB14012BurosumabNot AvailableAvailable1